Novocure (NVCR) announced that the FDA approved its new head flexible electrode, or HFE, transducer arrays for use with Optune Gio for the treatment of adult patients with glioblastoma multiforme, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback